Longtime Gilead CFO Washington set to retire, leaving new CEO O'Day a hole to fill

Gilead Sciences just got a new CEO in Daniel O'Day, and now it'll be in the market for a new CFO. The biotech's longtime financial chief, Robin Washington, plans to retire next March, setting the stage for another big executive search.